Ian S. Mitchell

772 total citations
26 papers, 342 citations indexed

About

Ian S. Mitchell is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Ian S. Mitchell has authored 26 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Hematology. Recurrent topics in Ian S. Mitchell's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Platelet Disorders and Treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Ian S. Mitchell is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Platelet Disorders and Treatments (4 papers) and Hemophilia Treatment and Research (4 papers). Ian S. Mitchell collaborates with scholars based in United States, United Kingdom and New Zealand. Ian S. Mitchell's co-authors include Amy D. Shapiro, Philip Magnus, Gerald Pattenden, Arthur Grimes, C. Michael Hall, Rui Xu, James F. Blake, Nicholas C. Kallan, Guy Vigers and Tyler Risom and has published in prestigious journals such as Blood, Tetrahedron Letters and Journal of Thrombosis and Haemostasis.

In The Last Decade

Ian S. Mitchell

23 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian S. Mitchell United States 11 115 100 75 31 27 26 342
Christelle Colin United States 12 64 0.6× 181 1.8× 17 0.2× 4 0.1× 14 0.5× 26 358
Neha Tripathi India 11 30 0.3× 146 1.5× 16 0.2× 19 0.6× 18 0.7× 45 393
Sylvia Ma United States 10 170 1.5× 281 2.8× 15 0.2× 7 0.2× 13 0.5× 11 437
William Dean United States 9 133 1.2× 71 0.7× 20 0.3× 40 1.3× 6 0.2× 34 257
Christopher M. Holman United States 9 16 0.1× 125 1.3× 17 0.2× 26 0.8× 8 0.3× 100 317
Diane Barnes United States 11 48 0.4× 207 2.1× 10 0.1× 4 0.1× 25 0.9× 14 424
Michael Malecki United States 9 13 0.1× 292 2.9× 28 0.4× 54 1.7× 9 0.3× 19 671
Davidson Nicol United Kingdom 6 23 0.2× 112 1.1× 14 0.2× 12 0.4× 15 0.6× 26 277
Ralph Hall United States 5 125 1.1× 113 1.1× 4 0.1× 5 0.2× 3 0.1× 7 234

Countries citing papers authored by Ian S. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Ian S. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian S. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian S. Mitchell more than expected).

Fields of papers citing papers by Ian S. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian S. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian S. Mitchell. The network helps show where Ian S. Mitchell may publish in the future.

Co-authorship network of co-authors of Ian S. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Ian S. Mitchell. A scholar is included among the top collaborators of Ian S. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian S. Mitchell. Ian S. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunn, Amy L., Yesim Dargaud, Manuel Carção, et al.. (2024). Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors. Haemophilia. 31(1). 78–86. 1 indexed citations
2.
Shapiro, Amy D., et al.. (2018). The future of bypassing agents for hemophilia with inhibitors in the era of novel agents. Journal of Thrombosis and Haemostasis. 16(12). 2362–2374. 44 indexed citations
3.
Johnson, Paul & Ian S. Mitchell. (2017). The Brexit vote, economics, and economic policy. Oxford Review of Economic Policy. 33(suppl_1). S12–S21. 9 indexed citations
4.
Wang, Michael, Jeanne B. Lawrence, Doris Quon, et al.. (2017). PERSEPT 1: a phase 3 trial of activated eptacog beta for on‐demand treatment of haemophilia inhibitor‐related bleeding. Haemophilia. 23(6). 832–843. 26 indexed citations
5.
Mitchell, Ian S.. (2017). The Implications of Brexit for UK, EU and Global Agricultural Reform in the Next Decade. 5 indexed citations
6.
Emmerson, Carl, Paul Johnson, Ian S. Mitchell, & David Phillips. (2016). Brexit could add two years to austerity. 2 indexed citations
7.
Guichon, Juliet, Ian S. Mitchell, & Christopher J. Doig. (2013). Assisted Human Reproduction in Common Law Canada after the Supreme Court of Canada Reference: Moving beyond Regulation by Colleges of Physicians and Surgeons. Canadian Journal of Women and the Law/Revue Femmes et Droit. 25(2). 315–339. 1 indexed citations
8.
Kallan, Nicholas C., Keith L. Spencer, James F. Blake, et al.. (2011). Discovery and SAR of spirochromane Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2410–2414. 33 indexed citations
9.
Xu, Rui, James F. Blake, Ian S. Mitchell, et al.. (2011). Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA. Bioorganic & Medicinal Chemistry Letters. 21(8). 2335–2340. 10 indexed citations
10.
Bencsik, Josef R., Dengming Xiao, James F. Blake, et al.. (2010). Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 7037–7041. 29 indexed citations
11.
Blake, James F., Nicholas C. Kallan, Dengming Xiao, et al.. (2010). Discovery of pyrrolopyrimidine inhibitors of Akt. Bioorganic & Medicinal Chemistry Letters. 20(19). 5607–5612. 46 indexed citations
12.
Friedman, Lori S., Susan L. Gloor, Sean M. Gross, et al.. (2010). 79 Preclinical characterization of GDC-0068, a novel selective ATP competitive inhibitor of Akt. European Journal of Cancer Supplements. 8(7). 33–33.
13.
Mitchell, Ian S., et al.. (2005). A total synthesis of the antitumour macrolide rhizoxin D. Organic & Biomolecular Chemistry. 3(24). 4412–4412. 19 indexed citations
14.
Magnus, Philip & Ian S. Mitchell. (1998). Synthesis of 3-methylindoles from N-aryl-N-(3-triisopropylsilylpropargyl)sulfonamides. Tetrahedron Letters. 39(26). 4595–4598. 17 indexed citations
15.
Magnus, Philip & Ian S. Mitchell. (1998). Hemi-thioacetal Pummerer reaction for the synthesis of gliovirin benzylic sulfide models. Tetrahedron Letters. 39(50). 9131–9134. 8 indexed citations
16.
Mitchell, Ian S., et al.. (1994). Platinum metal complexes of secondary phosphines: Synthesis and NMR spectroscopic studies of [M(PCy2H)3Cl]+, M = Pt, Pd. Polyhedron. 13(14). 2129–2133. 9 indexed citations
17.
Hall, C. Michael, et al.. (1992). Maori Culture and Heritage Tourism in New Zealand. Journal of Cultural Geography. 12(2). 115–128. 6 indexed citations
18.
Mitchell, Ian S. & John Cawte. (1977). The Aboriginal Family Voluntary Resettlement Scheme: An Approach to Aboriginal Adaptation. Australian & New Zealand Journal of Psychiatry. 11(1). 29–35. 2 indexed citations
19.
Mitchell, Ian S.. (1974). Paradoxes in Aboriginal Welfare. Australian Journal of Social Issues. 9(1). 56–60. 1 indexed citations
20.
Mitchell, Ian S.. (1968). Epilogue to a Referendum. Australian Journal of Social Issues. 3(4). 9–12. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026